首页> 外文OA文献 >Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association

【2h】

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association

机译：患有升级的Daunorubi蛋白和糖蛋白剂量的小鸡毒素的分级剂量剂量为Daunorubicin和Cytarabine作为50-70岁的患者的第一批急性骨髓性白血病：急性白血病法国协会的1/2研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; Leila Kammoun; Sylvain Chantepie; Claude Gardin; Philippe Rousselot; Sylvie Chevret; Hervé Dombret; Sylvie Castaigne;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association [J] . FarhatH., RemanO., RaffouxE., American Journal of Hematology . 2012,第1期

机译：在50-70岁患者中首次分批服用吉妥珠单抗ozogamicin和递增剂量的柔红霉素和阿糖胞苷作为急性髓细胞白血病的救治：急性白血病的1/2期研究（法国）
2. Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association? [J] . Hassan Farhat Oumedaly Reman Emmanuel Raffoux Celine Berthon Cécile Pautas Leila Kammoun Sylvain Chantepie Claude Gardin Philippe Rousselot Sylvie Chevret, Hervé Dombret Sylvie Castaigne AMERICAN JOURNAL OF HEMATOLOGY . 2012,第1期

机译：在50-70岁患者中，首先分次服用吉妥单抗ozogamicin，逐步增加剂量的柔红霉素和阿糖胞苷作为急性髓细胞白血病的救治方法：一项针对急性白血病的1/2期研究法国协会？
3. A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia [J] . FosterM.C., AminC., VoorheesP.M., Leukemia and lymphoma . 2012,第7期

机译：氯法拉滨联合难治性或复发性急性髓细胞性白血病患者联合氯法拉滨I级剂量递增研究
4. A Metadata-Based Patient Register for Cooperative Clinical Research: A Case Study in Acute Myeloid Leukemia [C] . Anja S. FISCHER, Ulrich MANSMANN Medical Informatics in Europe Conference. . 2011

机译：基于元数据的合作临床研究患者注册：急性髓性白血病案例研究
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy [O] . Marie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, 2016

机译：大剂量阿糖胞苷和米托蒽醌联合全反式维甲酸和吉妥珠单抗奥佐米星的挽救疗法在首次诱导治疗中难治的急性髓细胞白血病
7. A Phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia [O] . Charles A. Koller, Hagop M. Kantarjian, Eric J. Feldman, 1999

机译：一种升级剂量的尿催化剂升定剂量的氟妥甘露萘葡萄酒的升级剂量的I-II试验，作为急性白血病患者的救生疗法和慢性髓性白血病的弹性阶段

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association

著录项

相似文献

相关主题

期刊订阅